# US 2026/0193236 A1 · Linear heteroaryl diamide ire1/xbp1s activators

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0193236 A1
- Document ID: US20260193236A1
- Status: Published application
- Kind: A1
- Application number: 19/134,142
- Filed: 2023-11-29
- Published: 2026-07-09
- Earliest claimed: 2022-11-30
- Assignees: Protego Biopharma, Inc.
- Applicants: Protego Biopharma, Inc.
- Inventors: Richard F. LABAUDINIERE; Bradley Dean TAIT; Huang QIU; Hank Michael James PETRASSI; Bo QIN
- Web page: https://patentgrep.com/patent/US20260193236A1

## CPC

- C07D 403/12: linked by a chain containing hetero atoms as chain links
- A61K 31/4155: non condensed and containing further heterocyclic rings
- A61K 31/4196: 1,2,4-Triazoles
- A61K 31/433: Thidiazoles
- A61K 31/4355: the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
- A61K 31/437: the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A61K 31/4439: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465)
- A61K 31/444: containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A61K 31/4709: Non-condensed quinolines and containing further heterocyclic rings
- A61K 31/497: containing further heterocyclic rings
- A61K 31/506: not condensed and containing further heterocyclic rings
- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- A61P 25/16: Anti-Parkinson drugs
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C07B 59/002: {Heterocyclic compounds}
- C07D 231/40: Acylated on said nitrogen atom
- C07D 285/08: 1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 401/14: containing three or more hetero rings
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D 405/14: containing three or more hetero rings
- C07D 413/14: containing three or more hetero rings
- C07D 417/12: linked by a chain containing hetero atoms as chain links
- C07D 417/14: containing three or more hetero rings
- C07D 471/04: Ortho-condensed systems
- C07D 487/04: Ortho-condensed systems
- C07D 491/056: with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
- C07B 2200/05: Isotopically modified compounds, e.g. labelled
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

Provided herein are compounds that activate IREI/XBPIs, and pharmaceutically acceptable derivatives thereof. Also provided are pharmaceutical compositions containing the compounds and methods of using the compounds for treating a subject having a disease or disorder that may be ameliorated by increasing IREl/XBPls activity.

## Claims

### Claim 1

A compound of Formula I:
or a pharmaceutically acceptable derivative thereof, wherein:
m, n, p and s are each independently an integer from 0-4;
R1 is cycloalkyl or heterocycloalkyl;
R2 is aryl or heteroaryl;
X1 and X2 are each independently a bond, O, CONR15, SO2NR15 or NR15;
X3 and X4 are each independently CR16 or N;
X5 is CR17 or N;
R3, R4 and R15 are each independently H, alkyl, aryl or aralkyl;
R7 and R8 are each independently H, halo, alkyl, aryl or aralkyl, or together form spirocycloalkyl;
R11 and R12 are each independently H, halo, alkyl, aryl or aralkyl, or together form spirocycloalkyl; and
R5, R6, R9, R10, R13, R14, R16 and R17 are each independently H, halo, alkyl, aryl or aralkyl.

### Claim 2 (depends on 1)

The compound of claim 1, or a pharmaceutically acceptable derivative thereof, wherein:
R1 is cycloalkyl or heterocycloalkyl;
R2 is aryl or heteroaryl;
X1 and X2 are each independently a bond or O;
X3 and X4 are each independently CH or N;
X5 is CH; and
R3 to R15 are each independently H or alkyl.

### Claim 3 (depends on 1, 2)

The compound of claim 1 or claim 2, or a pharmaceutically acceptable derivative thereof, wherein:
R1 is cycloalkyl or heterocycloalkyl;
R2 is aryl or heteroaryl;
X1 and X2 are each independently a bond or O;
X3 and X4 are each independently CH or N;
X5 is CH; and
R3 to R15 are each independently H or methyl.

### Claim 4 (depends on 1, 2, 3)

The compound of any one of claims 1-3, or a pharmaceutically acceptable derivative thereof, wherein:
R1 is cycloalkyl;
R2 is aryl or heteroaryl;
X1 is a bond or O;
X2 is a bond, O or NR15;
X3 is CH or N;
X4 is CR16;
X5 is CR17 or N;
R3 to R17 are each independently H or methyl;
m and s are 0;
n is 0, 1, 2 or 3; and
p is 0 1, 2 or 3.

### Claim 5 (depends on 1, 2, 3, 4)

The compound of any one of claims 1-4, or a pharmaceutically acceptable derivative thereof, wherein:
R1 is cycloalkyl;
R2 is aryl or heteroaryl;
X1 is a bond or O;
X2 is a bond, O or NCH3;
X3 is CH or N;
X4 is CH or CCH3;
X5 is CH, CCH3 or N;
R4 and R9 are each independently H or methyl;
R3, R5 to R8, and R10 to R16 are each H;
m and s are 0;
n is 0, 1, 2 or 3; and
p is 0 1, 2 or 3.

### Claim 6 (depends on 1, 2, 3)

The compound of any one of claims 1-3, wherein R1 is cycloalkyl.

### Claim 7 (depends on 1, 2, 3)

The compound of any one of claims 1-3, wherein R1 is heterocycloalkyl.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6)

The compound of any one of claims 1-6, wherein R1 is cyclohexyl, optionally substituted with one of more alkyl or alkynyl substituents.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 8)

The compound of any one of claims 1-6 and 8, wherein R1 is cyclohexyl, optionally substituted with one or more methyl or ethynyl substituents.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 8, 9)

The compound of any one of claims 1-6, 8 and 9, wherein R1 is cyclohexyl, 2-ethynylcyclohexyl, 4,4-dimethylcyclohexyl or 2,2-dimethylcyclohexyl.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The compound of any one of claims 1-10, wherein R2 is phenyl or pyridyl.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The compound of any one of claims 1-11, wherein R2 is phenyl or pyridyl, each optionally substituted with alkyl, alkoxy, halo or haloalkyl.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The compound of any one of claims 1-12, wherein R2 is phenyl or pyridyl, each optionally substituted with methyl, methoxy, fluoro or trifluoromethyl.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The compound of any one of claims 1-10, wherein R2 is phenyl or pyridyl, each optionally substituted with alkyl, alkoxy, diazirinyl or haloalkyl.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 14)

The compound of any one of claims 1-10 and 14, wherein R2 is phenyl or pyridyl, each optionally substituted with methyl, methoxy, 3-(trifluoromethyl)-3H-diazirin-3-yl or trifluoromethyl.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The compound of any one of claims 1-15, wherein R2 is 4-methylphenyl, 4-methoxyphenyl, 4-fluorophenyl, 4-trifluoromethylphenyl or 2-pyridyl.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The compound of any one of claims 1-15, wherein R2 is phenyl, 4-methylphenyl, 4-trifluoromethylphenyl, 2-pyridyl, 5-trifluoromethyl-2-pyridyl, 4-methoxyphenyl or 3-(trifluoromethyl)-3H-diazirin-3-yl.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The compound of any one of claims 1-14, wherein R2 is 4-methylphenyl or 4-ethylphenyl.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

The compound of any one of claims 1-18, wherein X1 is a bond or O.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)

The compound of any one of claims 1-19, wherein X1 is a bond.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)

The compound of any one of claims 1-19, wherein X1 is O.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)

The compound of any one of claims 1-21, wherein X2 is a bond, O or NCH3.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The compound of any one of claims 1-22, wherein X2 is a bond or O.

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23)

The compound of any one of claims 1-23, wherein X2 is a bond.

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23)

The compound of any one of claims 1-23, wherein X2 is O.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The compound of any one of claims 1-22, wherein X2 is NCH3.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The compound of any one of claims 1-26, wherein X3 is N or CH.

### Claim 28 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)

The compound of any one of claims 1-27, wherein X4 is CH or CCH3.

### Claim 29 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The compound of any one of claims 1-26, wherein X3 is CH and X4 is N.

### Claim 30 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The compound of any one of claims 1-26, wherein X3 is N and X4 is CH.

### Claim 31 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)

The compound of any one of claims 1-30, wherein X5 is CR17.

### Claim 32 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)

The compound of any one of claims 1-31, wherein X5 is CH.

### Claim 33 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)

The compound of any one of claims 1-31, wherein X5 is CCH3.

### Claim 34 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)

The compound of any one of claims 1-30, wherein X5 is N.

### Claim 35 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

The compound of any one of claims 1-34, wherein R3, R4 and R15 are each independently H, alkyl, aryl or aralkyl, and R5 to R14, R16 and R17 are each independently H, halo, alkyl, aryl or aralkyl.

### Claim 36 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The compound of any one of claims 1-35, wherein R3, R4 and R15 are each independently H or alkyl.

### Claim 37 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)

The compound of any one of claims 1-36, wherein R3, R4 and R15 are each independently H or methyl.

### Claim 38 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The compound of any one of claims 1-37, wherein R5 to R14, R16 and R17 are each independently H or alkyl.

### Claim 39 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

The compound of any one of claims 1-38, wherein R5 to R14, R16 and R17 are each independently H or methyl.

### Claim 40 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

The compound of any one of claims 1-39, wherein R5 to R14, R16 and R17 are each independently H.

### Claim 41 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40)

The compound of any one of claims 1-40, wherein R3 is H or methyl.

### Claim 42 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)

The compound of any one of claims 1-41, wherein R4 is H or methyl.

### Claim 43 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42)

The compound of any one of claims 1-42, wherein R7 is H or methyl.

### Claim 44 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43)

The compound of any one of claims 1-43, wherein R9 is H or methyl.

### Claim 45 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)

The compound of any one of claims 1-44, wherein m is 0.

### Claim 46 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45)

The compound of any one of claims 1-45, wherein n is 2.

### Claim 47 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The compound of any one of claims 1-46, wherein p is 2.

### Claim 48 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47)

The compound of any one of claims 1-47, wherein s is 0.

### Claim 49 (depends on 1)

The compound of claim 1, wherein m and s are 0, n and p are 2, X3 is N, X4 and X5 are CH, R3 and R7-R12 are H, and R4 is methyl.

### Claim 50 (depends on 1)

The compound of claim 1, wherein m and s are 0, n and p are 2, X1 and X2 are O, X3 is N, X4 and X5 are CH, R3 and R7-R12 are H, and R4 is methyl.

### Claim 51 (depends on 1)

The compound of claim 1, wherein m and s are 0, n and p are 2, X1 and X2 are O, X3 is N, X4 and X5 are CH, R2 is 4-methylphenyl or 4-ethylphenyl, R3 and R7-R12 are H, and R4 is methyl.

### Claim 52 (depends on 1)

The compound of claim 1, wherein m and s are 0, n and p are 2, X1 and X2 are O, X3 is N, X4 and X5 are CH, R1 is optionally substituted cycloalkyl, R2 is 4-methylphenyl or 4-ethylphenyl, R3 and R7-R12 are H, and R4 is methyl.

### Claim 53 (depends on 1)

The compound of claim 1, wherein m and s are 0, n and p are 2, X1 and X2 are O, X3 is N, X4 and X5 are CH, R1 is optionally substituted cyclohexyl, R2 is 4-methylphenyl or 4-ethylphenyl, R3 and R7-R12 are H, and R4 is methyl.

### Claim 54

A compound of Formula II:
or a pharmaceutically acceptable derivative thereof, wherein:
a and b are each independently 2 or 3;
R21 is heteroaryl, cycloalkyl or heterocycloalkyl;
R22 is aryl or heteroaryl;
X21 is a bond, O, CONR30, SO2NR30 or NR30;
X22 is O, CONR31, SO2NR31 or NR31; and
R23 and R24 are each independently H, alkyl, aryl, aralkyl, or together form spirocycloalkyl;
R28 and R29 are each independently H, alkyl, aryl, aralkyl, or together form spirocycloalkyl;
R25, R26, R27, R30 and R31 are each independently H, alkyl or aralkyl;
with the proviso that R21 is not optionally substituted 2-pyridyl.

### Claim 55 (depends on 54)

The compound of claim 54, wherein a is 2.

### Claim 56 (depends on 54)

The compound of claim 54, wherein a is 3.

### Claim 57 (depends on 54, 55, 56)

The compound of any one of claims 54-56, wherein b is 2.

### Claim 58 (depends on 54, 55, 56)

The compound of any one of claims 54-56, wherein b is 3.

### Claim 59 (depends on 54, 55, 56, 57, 58)

The compound of any one of claims 54-58, wherein R21 is heteroaryl.

### Claim 60 (depends on 54, 55, 56, 57, 58, 59)

The compound of any one of claims 54-59, wherein R21 is heteroaryl optionally substituted with one or more substituents each independently selected from oxo, halo, amino, alkyl and haloalkyl.

### Claim 61 (depends on 54, 55, 56, 57, 58, 59, 60)

The compound of any one of claims 54-60, wherein R21 is pyridyl optionally substituted with one or more substituents each independently selected from oxo, halo, amino, alkyl and haloalkyl.

### Claim 62 (depends on 54, 55, 56, 57, 58, 59, 60, 61)

The compound of any one of claims 54-61, wherein R21 is 3-pyridyl or 4-pyridyl, each optionally substituted with one or more substituents each independently selected from oxo, halo, amino, alkyl and haloalkyl.

### Claim 63 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62)

The compound of any one of claims 54-62, wherein R21 is 3-pyridyl or 4-pyridyl, each optionally substituted with one or more substituents each independently selected from oxo, chloro, fluoro, amino, methyl, isopropyl and trifluoromethyl.

### Claim 64 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63)

The compound of any one of claims 54-63, wherein R21 is 3-pyridyl, 4-oxo-1-pyridyl, 2-chloro-4-pyridyl, 4-pyridyl, 6-fluoro-2-methyl-3-pyridyl, 2,6-dimethyl-3-pyridyl, 4-trifluoromethyl-3-pyridyl, 2-methyl-3-pyridyl, 2,4-dimethyl-3-pyridyl, 2-methyl-4-isopropyl-3-pyridyl, 2-trifluoromethyl-3-pyridyl, 2-amino-4-methyl-3-pyridyl, 3,5-difluoro-4-pyridyl or 3-fluoro-4-pyridyl.

### Claim 65 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64)

The compound of any one of claims 54-64, wherein R21 is 3-pyridyl, 4-pyridyl, 6-fluoro-2-methyl-3-pyridyl or 3,5-difluoro-4-pyridyl.

### Claim 66 (depends on 54, 55, 56, 57, 58)

The compound of any one of claims 54-58, wherein R21 is cycloalkyl.

### Claim 67 (depends on 54, 55, 56, 57, 58)

The compound of any one of claims 54-58, wherein R21 is heterocycloalkyl.

### Claim 68 (depends on 54, 55, 56, 57, 58, 66)

The compound of any one of claims 54-58 and 66, wherein R21 is cyclohexyl, optionally substituted with one of more alkyl or alkynyl substituents.

### Claim 69 (depends on 54, 55, 56, 57, 58, 66, 68)

The compound of any one of claims 54-58, 66 and 68, wherein R21 is cyclohexyl, 2-ethynylcyclohexyl, 4,4-dimethylcyclohexyl or 2,2-dimethylcyclohexyl.

### Claim 70 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69)

The compound of any one of claims 54-69, wherein R22 is aryl.

### Claim 71 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69)

The compound of any one of claims 54-69, wherein R22 is heteroaryl.

### Claim 72 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70)

The compound of any one of claims 54-70, wherein R22 is aryl, optionally substituted with alkyl or haloalkyl.

### Claim 73 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 72)

The compound of any one of claims 54-70 and 72, wherein R22 is phenyl, optionally substituted with alkyl or haloalkyl.

### Claim 74 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 72, 73)

The compound of any one of claims 54-70, 72 and 73, wherein R22 is phenyl, optionally substituted with methyl or trifluoromethyl.

### Claim 75 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74)

The compound of any one of claims 54-74, wherein X21 is a bond.

### Claim 76 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74)

The compound of any one of claims 54-74, wherein X21 is O.

### Claim 77 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74)

The compound of any one of claims 54-74, wherein X21 is NH.

### Claim 78 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77)

The compound of any one of claims 54-77, wherein X22 is O.

### Claim 79 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77)

The compound of any one of claims 54-77, wherein X22 is NH.

### Claim 80 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79)

The compound of any one of claims 54-79, wherein R23 to R29 are each H.

### Claim 81 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80)

The compound of any one of claims 54-80, wherein the compound has Formula IIa:
or a pharmaceutically acceptable derivative thereof, where R21 is heteroaryl; with the proviso that R21 is not optionally substituted 2-pyridyl.

### Claim 82

A compound that has Formula III:
or a pharmaceutically acceptable derivative thereof, where R40 is aryl or heteroaryl.

### Claim 83 (depends on 82)

The compound of claim 82, wherein R40 is aryl or heteroaryl, each optionally substituted with one or more substituents selected from halo, alkyl, haloalkyl, alkoxy, haloalkoxy, cycloalkyl or heterocycloalkyl.

### Claim 84 (depends on 82, 83)

The compound of claim 82 or claim 83, wherein R40 is phenyl or pyridyl, each optionally substituted with one or more substituents selected from halo, alkyl, haloalkyl, alkoxy, haloalkoxy or cycloalkyl.

### Claim 85 (depends on 82, 83, 84)

The compound of any one of claims 82-84, wherein R40 is phenyl or pyridyl, each optionally substituted with one or more substituents selected from chloro, fluoro, methyl, trifluoromethyl, methoxy, trifluromethoxy or cyclopropyl.

### Claim 86 (depends on 82, 83, 84, 85)

The compound of any one of claims 82-85, wherein R40 is phenyl, optionally substituted with one or more substituents selected from chloro, fluoro, methyl, trifluoromethyl, methoxy, trifluromethoxy or cyclopropyl.

### Claim 87 (depends on 82, 83, 84, 85)

The compound of any one of claims 82-85, wherein R40 is pyridyl, optionally substituted with one or more substituents selected from chloro, fluoro, methyl, trifluoromethyl, methoxy, trifluromethoxy or cyclopropyl.

### Claim 88 (depends on 82, 83, 84, 85, 87)

The compound of any one of claims 82-85 and 87, wherein R40 is 2-pyridyl, optionally substituted with one or more substituents selected from chloro, fluoro, methyl, trifluoromethyl, methoxy, trifluromethoxy or cyclopropyl.

### Claim 89 (depends on 82, 83, 84, 85, 87, 88)

The compound of any one of claims 82-85, 87 and 88, wherein R40 is 2-pyridyl, optionally substituted with one or more fluoro substituents.

### Claim 90 (depends on 82, 83, 84, 85)

The compound of any one of claims 82-85, wherein R40 is 4-methylphenyl, 4-trifluoromethylphenyl, 3-trifluoromethoxyphenyl, 3,4-difluorophenyl, 4-chlorophenyl, 3-chloro-4-fluorophenyl, 4-cyclopropylphenyl, 3-methoxyphenyl, 4-fluorophenyl, 3-chloro-4-methylphenyl, 4-methoxyphenyl, 4-fluoro-3-trifluoromethoxyphenyl, 4-methyl-3-trifluoromethylphenyl or 3,5-difluoro-2-pyridyl.

### Claim 91

A compound of Formula IV:
or a pharmaceutically acceptable derivative thereof, wherein R41 is phenyl, 2-fluorophenyl or 2,6-difluorophenyl; and R42 is ethyl or trifluoromethyl; with the proviso that the compound is not N-(1-(2-(methyl-(2-(4-(trifluoromethyl)phenoxy)ethyl)amino)-2-oxoethyl)-1H-pyrazol-4-yl)-3-phenoxypropanamide.

### Claim 92

A compound of Formula V:
or a pharmaceutically acceptable derivative thereof, wherein R43 is alkoxy or halo; and R44 is aryl, heteroaryl, cycloalkyl or heterocycloalkyl; with the proviso that the compound is not N-(1-(2-(methyl-(2-(p-tolyloxy)ethyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)-3-(2-fluorophenoxy)propanamide.

### Claim 93 (depends on 92)

The compound of claim 92, wherein R43 is alkoxy or chloro.

### Claim 94 (depends on 92, 93)

The compound of claim 92 or claim 93, wherein R43 is methoxy or chloro.

### Claim 95 (depends on 92, 93, 94)

The compound of any one of claims 92-94, wherein R44 is aryl or heteroaryl.

### Claim 96 (depends on 92, 93, 94, 95)

The compound of any one of claims 92-95, wherein R44 is aryl.

### Claim 97 (depends on 92, 93, 94, 95, 96)

The compound of any one of claims 92-96, wherein R44 is phenyl, optionally substituted with alkyl.

### Claim 98 (depends on 92, 93, 94, 95, 96, 97)

The compound of any one of claims 92-97, wherein R44 is 4-methylphenyl.

### Claim 99

A compound of Formula VI:
or a pharmaceutically acceptable derivative thereof, wherein R45 and R46 are each independently aryl, heteroaryl, cycloalkyl or heterocycloalkyl.

### Claim 100 (depends on 99)

The compound of claim 99, wherein R45 and R46 are each independently aryl or heteroaryl.

### Claim 101 (depends on 99, 100)

The compound of claim 99 or claim 100, wherein R45 and R46 are each independently aryl.

### Claim 102 (depends on 99, 100, 101)

The compound of any one of claims 99-101, wherein R45 and R46 are each independently aryl, optionally substituted with alkyl.

### Claim 103 (depends on 99, 100, 101, 102)

The compound of any one of claims 99-102, wherein R45 and R46 are each independently phenyl, optionally substituted with methyl.

### Claim 104 (depends on 99, 100, 101, 102, 103)

The compound of any one of claims 99-103, wherein R45 is phenyl.

### Claim 105 (depends on 99, 100, 101, 102, 103, 104)

The compound of any one of claims 99-104, wherein R46 is 4-methylphenyl.

### Claim 106

A compound of Formula VII:
or a pharmaceutically acceptable derivative thereof, wherein R21 is aryl, heteroaryl, cycloalkyl or heterocycloalkyl; R22 is aryl or heteroaryl; R23, R28 and R29 are each independently H or alkyl with the proviso that at least one of R23, R28 and R29 is alkyl; and with the proviso that the compound is not N-(1-(2-(methyl-(2-(p-tolyloxy)ethyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)-3-(4-fluorophenoxy)-2-methylpropanamide.

### Claim 107 (depends on 106)

The compound of claim 106, wherein R23 is alkyl, and R28 and R29 are both H.

### Claim 108 (depends on 106)

The compound of claim 106, wherein R23 is H, and R28 and R29 are both alkyl.

### Claim 109 (depends on 106)

The compound of claim 106, wherein R28 is alkyl and R23 and R29 are both H.

### Claim 110 (depends on 106)

The compound of claim 106, wherein R23 is methyl, and R28 and R29 are both H.

### Claim 111 (depends on 106)

The compound of claim 106, wherein R23 is H, and R28 and R29 are both methyl.

### Claim 112 (depends on 106)

The compound of claim 106, wherein R28 is methyl and R23 and R29 are both H.

### Claim 113

A compound selected from Compounds 1-295.

### Claim 114 (depends on 1, 113)

A pharmaceutical composition, comprising a compound of any one of claims 1-113 and a pharmaceutically acceptable carrier.

### Claim 115 (depends on 1, 113, 114)

A method of treating a disease or disorder selected from a cardiovascular disease, neurodegenerative disease, metabolic disorder, hepatic disorder, protein misfolding disorder or gastrointestinal disorder in a subject, comprising administering to the subject the compound of any one of claims 1-113 or the pharmaceutical composition of claim 114.

### Claim 116 (depends on 115)

The method of claim 115, wherein the cardiovascular disease is myocardial infarction or atherosclerosis.

### Claim 117 (depends on 115)

The method of claim 115, wherein the neurodegenerative disease is peripheral nerve injury, Creutzfeldt-Jakob disease, Parkinson's disease or Huntington's disease.

### Claim 118 (depends on 115)

The method of claim 115, wherein the metabolic disorder is diabetes, type II diabetes or Gaucher disease.

### Claim 119 (depends on 115)

The method of claim 115, wherein the hepatic disorder is non-alcoholic fatty liver disease (NAFLD).

### Claim 120 (depends on 115)

The method of claim 115, wherein the hepatic disorder is Progressive familial intrahepatic cholestasis (PFIC), Benign recurrent intrahepatic cholestasis (BRIC) or Wilson's disease.

### Claim 121 (depends on 115)

The method of claim 115, wherein the protein misfolding disorder is an amyloid disease, Alzheimer's disease, an ocular disease, retinal degeneration, a lysosomal storage disease or alpha-1 antitrypsin deficiency, including alpha-1 antitrypsin associated emphysema and alpha-1 antitrypsin associated liver disease.

### Claim 122 (depends on 121)

The method of claim 121, wherein the amyloid disease is atrial amyloidosis, spongiform encephalopathies, senile systemic amyloidosis, hereditary cerebral amyloid angiopathy, familial amyloid polyneuropathy I and II, or familial amyloidosis.

### Claim 123 (depends on 115)

The method of claim 115, wherein the gastrointestinal disorder is Crohn's disease.

### Claim 124 (depends on 1, 113, 114)

A method of treating retinitis pigmentosa, achromatopsia, diabetic retinopathy or retinal neurodegeneration in a subject, comprising administering to the subject the compound of any one of claims 1-113 or the pharmaceutical composition of claim 114.

### Claim 125 (depends on 1, 113, 114)

A method of treating idiopathic epilepsy in a subject, comprising administering to the subject the compound of any one of claims 1-113 or the pharmaceutical composition of claim 114.

### Claim 126 (depends on 1, 113, 114)

A method of treating chondrodysplasia in a subject, comprising administering to the subject the compound of any one of claims 1-113 or the pharmaceutical composition of claim 114.

### Claim 127 (depends on 1, 113, 114)

A method of increasing IRE1 or XBP1s activity in a subject, comprising administering to the subject a compound of any one of claims 1-113 or a pharmaceutical composition of claim 114.

### Claim 128 (depends on 1, 113, 114)

A method of treating idiopathic epilepsy, Dravet syndrome or Lennox-Gastaut syndrome in a subject, comprising administering to the subject the compound of any one of claims 1-113 or the pharmaceutical composition of claim 114.

### Claim 129 (depends on 1, 113, 114)

A method of treating genetic epilepsy in a subject, comprising administering to the subject the compound of any one of claims 1-113 or the pharmaceutical composition of claim 114.

### Claim 130 (depends on 1, 113, 114)

A method of treating genetic epilepsy due to at least one variant in GABAA receptor subunits in a subject, comprising administering to the subject the compound of any one of claims 1-113 or the pharmaceutical composition of claim 114.
